Solari, A;
Giordano, A;
Sastre-Garriga, J;
Köpke, S;
Rahn, A. C;
Kleiter, I;
Aleksovska, K;
Battaglia, M. A;
Bay, J;
Copetti, M;
Drulovic, J;
Kooij, L;
Mens, J;
Meza Murillo, E. R;
Milanov, I;
Milo, R;
Pekmezovic, T;
Vosburgh, J;
Silber, E;
Veronese, S;
Patti, F;
Voltz, R;
Oliver, D.
Background and purpose
Patients with severe, progressive multiple sclerosis (MS) have complex physical and psychosocial needs, typically over several years. Few treatment options are available to prevent or delay further clinical worsening in this population. The objective was to develop an evidence-base...
This guideline covers assessing and managing motor neurone disease (MND). It aims to improve care from the time of diagnosis, and covers information and support, organisation of care, managing symptoms and preparing for end of life care....
This guideline covers managing spasticity and co-existing motor disorders and their early musculoskeletal complications in children and young people (from birth up to their 19th birthday) with non-progressive brain disorders. It aims to reduce variation in practice and help healthcare professionals to se...
Muscle Spasticity/therapy,
Muscle Spasticity/diagnosis,
Muscle Spasticity/drug therapy,
Pain Management,
Diazepam/therapeutic use,
Baclofen/therapeutic use,
Trihexyphenidyl/therapeutic use,
Levodopa/therapeutic use,
Botulinum Toxins, Type A/therapeutic use,
Rhizotomy
